Titre :
  • TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancer.
Auteur : Moretti, Erica ; Desmedt, Christine ; Biagioni, Chiara ; Regan, Meredith M ; Oakman, Catherine ; Larsimont, Denis ; Galardi, Francesca ; Piccart-Gebhart, Martine ; Sotiriou, Christos ; Rimm, David L ; Di Leo, Angelo
Informations sur la publication : Future oncology, 9, 10, (page 1477-1487)
Statut de publication : Publié, 2013-10
Sujet CREF : Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Mots-clés : anthracyclines
biomarker
breast cancer
quantitative immunofluorescence
TOP2A
Mots-clés MeSH : Antigens, Neoplasm -- genetics -- metabolism
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- mortality
Cell Nucleus -- metabolism
Cytoplasm -- metabolism
DNA Topoisomerases, Type II -- genetics -- metabolism
DNA-Binding Proteins -- genetics -- metabolism
Epirubicin -- therapeutic use
Female
Humans
Immunohistochemistry
Neoadjuvant Therapy
Prognosis
Protein Transport
Topoisomerase II Inhibitors -- therapeutic use
Note : Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:1479-6694 
info:doi/10.2217/fon.13.103
info:pmid/24106899